Wednesday, October 9, 2019

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug The tentative nod granted by US Food Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for multiple strengths of dimethyl fumarate delayed-release capsules of 120 mg and 240 mg.

from Moneycontrol Business News https://ift.tt/2LWLFDH
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...